Related references
Note: Only part of the references are listed.IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment
Carla M. Felcher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Recombinant Human IL-11 Promotes Lung Adenocarcinoma A549 Cell Growth and EMT through Activating STAT3/HIF-1α/EMT Signaling Pathway
Na Peng et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis
Andrew F. Irvine et al.
SCIENTIFIC REPORTS (2021)
The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
Baharia Mograbi et al.
DIAGNOSTICS (2021)
STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
Elvire Pons-Tostivint et al.
CELLS (2021)
NFAT as a Biomarker and Therapeutic Target in Non-Small Cell Lung Cancer-Related Brain Metastasis
Lu Peng et al.
FRONTIERS IN ONCOLOGY (2021)
Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts
Anissa A. Widjaja et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis
Ankur Jain et al.
BLOOD CELLS MOLECULES AND DISEASES (2021)
Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway
Huaying Wang et al.
ONCOLOGY LETTERS (2021)
Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases
Cheng Chen et al.
JOURNAL OF THORACIC DISEASE (2021)
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma
Tao Fan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer
Jinnan Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)
Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab
M. Teresa Agullo-Ortuno et al.
CLINICAL LUNG CANCER (2020)
Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation
Stuart A. Cook et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Pneumothorax rates in CT-Guided lung biopsies: a comprehensive systematic review and meta-analysis of risk factors
Ya Ruth Huo et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease
Benjamin Ng et al.
FASEB JOURNAL (2020)
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Michael A. Gillette et al.
CELL (2020)
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
Jun-Yu Xu et al.
CELL (2020)
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Yi-Ju Chen et al.
CELL (2020)
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
Riley D. Metcalfe et al.
FRONTIERS IN IMMUNOLOGY (2020)
miR-495 and miR-5688 are down-regulated in non-small cell lung cancer under hypoxia to maintain interleukin-11 expression
Meng Zhao et al.
CANCER COMMUNICATIONS (2020)
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt et al.
CLINICAL SCIENCE (2020)
Prognostic value of immune related genes in lung adenocarcinoma
Han Wang et al.
ONCOLOGY LETTERS (2020)
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
Benjamin Ng et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
Jun Ma et al.
CANCER RESEARCH AND TREATMENT (2019)
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis
Taichi Matsubara et al.
CLINICAL LUNG CANCER (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
Dongyao Wang et al.
EBIOMEDICINE (2019)
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Jordi Alcaraz et al.
LUNG CANCER (2019)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Benjamin Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma
Jun W. Kim et al.
NATURE MEDICINE (2019)
Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
Jing Ye et al.
MEDIATORS OF INFLAMMATION (2019)
Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer
Greg J. Haro et al.
JAMA NETWORK OPEN (2019)
Interleukin-6 Family Cytokines
Stefan Rose-John
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
Upregulation of IL-11,an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer
Meng Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Increased interleukin-11 levels in thoracic aorta and plasma from patients with acute thoracic aortic dissection
Yao Xu et al.
CLINICA CHIMICA ACTA (2018)
IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
Nese Unver et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1
Xiaoxun Wang et al.
EXPERIMENTAL CELL RESEARCH (2018)
The Role of Interleukin-31 Polymorphisms in Non-Small Cell Lung Cancer Genetic Susceptibility and Clinical Outcome
Yongfeng Yang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma
Bin Xu et al.
ONCOLOGY LETTERS (2018)
Signal transducer and activator of transcription3 overexpression promotes lymph node micrometastasis in early-stage non-small cell lung cancer
Yang Yu et al.
THORACIC CANCER (2018)
Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes
Donovan Watza et al.
CARCINOGENESIS (2018)
TAIWAN LUNG CANCER SCREENING PROGRAM FOR NEVER SMOKERS
RESPIROLOGY (2018)
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones et al.
NATURE REVIEWS IMMUNOLOGY (2018)
A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer
Yunhua Xu et al.
JOURNAL OF CANCER (2018)
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Eisuke Kato et al.
ERJ OPEN RESEARCH (2018)
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer
Kazuhiko Shien et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Toil enables reproducible, open source, big biomedical data analyses
John Vivian et al.
NATURE BIOTECHNOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis
Mengting Tong et al.
PLOS ONE (2017)
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma
Claire L. Meaney et al.
ONCOTARGET (2017)
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Estela Maria Silva et al.
PLOS ONE (2017)
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer Analysis of Clinical Samples and BMTP-11 Preclinical Activity
Marina Cardo-Vila et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
Gavin D. Brooks et al.
CANCER RESEARCH (2016)
Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer
D. Q. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2016)
IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF)
Maria Delores Pastor et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma
Chiung-Hung Hsu et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
Leilei Tao et al.
SCIENTIFIC REPORTS (2016)
Proteolytic Cleavage Governs Interleukin-11 Trans-signaling
Juliane Lokau et al.
CELL REPORTS (2016)
Interleukin-11 alters placentation and causes preeclampsia features in mice
Amy L. Winship et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Prognostic value of circulating inflammatory factors in non-small cell lung cancer: A systematic review and meta-analysis
Chen Liao et al.
CANCER BIOMARKERS (2014)
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Susan Heavey et al.
CANCER TREATMENT REVIEWS (2014)
Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients
E. -M. Reitter et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Molecular Pathways: IL11 as a Tumor-Promoting Cytokine-Translational Implications for Cancers
Matthias Ernst et al.
CLINICAL CANCER RESEARCH (2014)
Proteomic Analysis of Proteins Related to Prognosis of Lung Adenocarcinoma
Akiko Okayama et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
Lanxi Song et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer
Chuanli Ren et al.
TUMOR BIOLOGY (2014)
Treatment of Stage I and II Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John A. Howington et al.
CHEST (2013)
Quantitative Proteomics Profiling of Primary Lung Adenocarcinoma Tumors Reveals Functional Perturbations in Tumor Metabolism
Maria Pernemalm et al.
JOURNAL OF PROTEOME RESEARCH (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway
Li Ren et al.
MEDICAL ONCOLOGY (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
High COL4A3 expression correlates with poor prognosis after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer
Cheng-Ping Jiang et al.
TUMOR BIOLOGY (2013)
Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo
Silvestre Vicent et al.
CANCER RESEARCH (2012)
The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis
Simon Ekman et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers
Takefumi Kikuchi et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R. Kratz et al.
LANCET (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A systems view of epithelial-mesenchymal transition signaling states
Stuart Thomson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Current technological challenges in biomarker discovery and validation
Peter L. Horvatovich et al.
EUROPEAN JOURNAL OF MASS SPECTROMETRY (2010)
The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development
Meegan Howlett et al.
GASTROENTEROLOGY (2009)
Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors
Marcin Wysoczynski et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
Matthias Ernst et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas
D. R. Chen et al.
JOURNAL OF PATHOLOGY (2008)
Turning gray: The natural history of lung cancer over time
Frank C. Detterbeck et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
Differential diagnosis of pleural effusions by fuzzy-logic-based analysis of cytokines
P Chomej et al.
RESPIRATORY MEDICINE (2004)
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer
DJ McKeown et al.
BRITISH JOURNAL OF CANCER (2004)
Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells
MJ Spence et al.
CYTOKINE (2002)
Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells
M Saitoh et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Share Paper
